Could fasting boost cancer treatment? early safety study begins
NCT ID NCT04387084
Summary
This small, early-stage study is testing whether short-term fasting before standard immunotherapy is safe and practical for people with advanced skin cancer. Researchers want to see if patients can follow the fasting schedule and if it causes serious side effects. The hope is that fasting might reduce treatment side effects or make the immunotherapy work better, but this is a preliminary safety check.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SKIN NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles General Medical Center
Los Angeles, California, 90033, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.